Browsing by Author "Fogel, Mark A."

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Design and implementation of multicenter pediatric and congenital studies with cardiovascular magnetic resonance: Big data in smaller bodies
    (Elsevier, 2024) DiLorenzo, Michael P.; Lee, Simon; Rathod, Rahul H.; Raimondi, Francesca; Farooqi, Kanwal M.; Jain, Supriya S.; Samyn, Margaret M.; Johnson, Tiffanie R.; Olivieri, Laura J.; Fogel, Mark A.; Lai, Wyman W.; Renella, Pierangelo; Powell, Andrew J.; Buddhe, Sujatha; Stafford, Caitlin; Johnson, Jason N.; Helbing, Willem A.; Pushparajah, Kuberan; Voges, Inga; Muthurangu, Vivek; Miles, Kimberley G.; Greil, Gerald; McMahon, Colin J.; Slesnick, Timothy C.; Fonseca, Brian M.; Morris, Shaine A.; Soslow, Jonathan H.; Grosse-Wortmann, Lars; Beroukhim, Rebecca S.; Grotenhuis, Heynric B.; Pediatrics, School of Medicine
    Cardiovascular magnetic resonance (CMR) has become the reference standard for quantitative and qualitative assessment of ventricular function, blood flow, and myocardial tissue characterization. There is a preponderance of large CMR studies and registries in adults; However, similarly powered studies are lacking for the pediatric and congenital heart disease (PCHD) population. To date, most CMR studies in children are limited to small single or multicenter studies, thereby limiting the conclusions that can be drawn. Within the PCHD CMR community, a collaborative effort has been successfully employed to recognize knowledge gaps with the aim to embolden the development and initiation of high-quality, large-scale multicenter research. In this publication, we highlight the underlying challenges and provide a practical guide toward the development of larger, multicenter initiatives focusing on PCHD populations, which can serve as a model for future multicenter efforts.
  • Thumbnail Image
    Item
    Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association
    (Wolters Kluwer, 2022) Fogel, Mark A.; Anwar, Shaftkat; Broberg, Craig; Browne, Lorna; Chung, Taylor; Johnson, Tiffanie; Muthurangu, Vivek; Taylor, Michael; Valsangiacomo-Buechel, Emanuela; Wilhelm, Carolyn; Pediatrics, School of Medicine
    Cardiovascular magnetic resonance has been utilized in the management and care of pediatric patients for nearly 40 years. It has evolved to become an invaluable tool in the assessment of the littlest of hearts for diagnosis, pre-interventional management and follow-up care. Although mentioned in a number of consensus and guidelines documents, an up-to-date, large, stand-alone guidance work for the use of cardiovascular magnetic resonance in pediatric congenital 36 and acquired 35 heart disease endorsed by numerous Societies involved in the care of these children is lacking. This guidelines document outlines the use of cardiovascular magnetic resonance in this patient population for a significant number of heart lesions in this age group and although admittedly, is not an exhaustive treatment, it does deal with an expansive list of many common clinical issues encountered in daily practice.
  • Thumbnail Image
    Item
    Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association
    (BMC, 2022-06-21) Fogel, Mark A.; Anwar, Shaftkat; Broberg, Craig; Browne, Lorna; Chung, Taylor; Johnson, Tiffanie; Muthurangu, Vivek; Taylor, Michael; Valsangiacomo‑Buechel, Emanuela; Wilhelm, Carolyn; Pediatrics, School of Medicine
    Cardiovascular magnetic resonance (CMR) has been utilized in the management and care of pediatric patients for nearly 40 years. It has evolved to become an invaluable tool in the assessment of the littlest of hearts for diagnosis, pre-interventional management and follow-up care. Although mentioned in a number of consensus and guidelines documents, an up-to-date, large, stand-alone guidance work for the use of CMR in pediatric congenital 36 and acquired 35 heart disease endorsed by numerous Societies involved in the care of these children is lacking. This guidelines document outlines the use of CMR in this patient population for a significant number of heart lesions in this age group and although admittedly, is not an exhaustive treatment, it does deal with an expansive list of many common clinical issues encountered in daily practice.